OpenVSafe by OpenVAERS
Search V-safe

C7Z-88711-66649

4 vaccinations 4 coded responses 37 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
211 / MD
Registered
2020-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Registered in v-safe
  2. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-21
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-04
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-12
    Survey response — 3 months, dose 2
    MedDRA: Gestational diabetes — Feeling: Good
    Free text: Gestational diabetes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-07-12
    Survey response — 6 months, dose 2
    MedDRA: Gestational diabetes — Feeling: Good
    Free text: Gestational diabetes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-09-27
    Dose 3 — Pfizer-BioNTech
  21. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  22. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  23. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  24. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  25. 2021-10-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  26. 2021-10-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-10-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  28. 2021-10-25
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-11-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-11-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-12-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-03-30
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-09-21
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  34. 2022-09-27
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-10-04
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-10-05
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-10-12
    Survey response — day 21, dose 4
    MedDRA: Abdominal discomfort, Nausea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: GI upset/nausea
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-10-19
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-10-26
    Survey response — day 35, dose 4
    MedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Congestion, runny nose, headache
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-11-02
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  41. 2022-12-21
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  42. 2023-03-22
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech
32021-09-27Pfizer-BioNTech No
42022-09-21Pfizer-BioNTech Flu

Free text

Release 7 — 3 months, dose 2

2021-04-12

Symptoms: Gestational diabetes

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Gestational diabetes

Release 12 — day 21, dose 4

2022-10-12

Symptoms: GI upset/nausea

Release 12 — day 35, dose 4

2022-10-26

Symptoms: Congestion, runny nose, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort · · ✓
SDGestational diabetes ✓ ✓ ✓
SDHeadache · · ✓
SDNausea · · ✓
SDRespiratory tract congestion · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…